Cerus
CERS
#7336
Rank
C$0.62 B
Marketcap
C$3.26
Share price
0.00%
Change (1 day)
39.95%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.29 Million, an increase over its 2023 earnings that were of -C$39.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-37.1%
2024 -C$16.29 Million-58.95%
2023 -C$39.66 Million-20.74%
2022 -C$50.04 Million-25.7%
2021 -C$67.35 Million-11.99%
2020 -C$76.52 Million-14%
2019 -C$88.98 Million21.73%
2018 -C$73.09 Million-0.65%
2017 -C$73.57 Million-10.96%
2016 -C$82.63 Million4.24%
2015 -C$79.27 Million50.99%
2014 -C$52.5 Million-10.08%
2013 -C$58.39 Million184.13%
2012 -C$20.55 Million-7.91%
2011 -C$22.32 Million
2009 -C$31.52 Million-24.69%
2008 -C$41.85 Million-25.2%
2007 -C$55.94 Million330.54%
2006 -C$13 Million1.49%
2005 -C$12.81 Million-61.02%
2004 -C$32.85 Million
2002 -C$81.25 Million10.02%
2001 -C$73.85 Million34.25%
2000 -C$55.01 Million61.02%
1999 -C$34.17 Million-18.81%
1998 -C$42.08 Million93.08%
1997 -C$21.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$4.48 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.03 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.33 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.01 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA